𝔖 Bobbio Scriptorium
✦   LIBER   ✦

RETRACTED: The prognostic and predictive value of immunohistochemically detected HER-2/neu overexpression in 361 patients with ovarian cancer: a multicenter study

✍ Scribed by Eva-Katrin Riener; Norbert Arnold; Friedrich Kommoss; Stefan Lauinger; Jacobus Pfisterer


Book ID
113959439
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
145 KB
Volume
95
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Distribution of HER-2 overexpression in
✍ Estrid V. S. HΓΈgdall; Lise Christensen; Susanne K. Kjaer; Jan Blaakaer; Johannes πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 389 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The HER‐2 (Human Epidermal Growth factor receptor‐2, also known as c‐__erb__‐2/__neu__) protooncogene encodes a transmembrane receptor protein, __M__~r~ 185,000. Studies have shown that the HER‐2 oncogene is overexpressed in approximately 25–30% of ovarian carcinoma (OC)

Prognostic value of the quantitative mea
✍ Uriel Bohn; JosΓ© Aguiar; Cristina Bilbao; Adolfo Murias; Victor Vega; Ricardo Ch πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 109 KB

## Abstract Our study attempts to determine the prognostic value of the quantitative measurement of the oncoprotein p185^Her‐2/neu^ in a group of patients with breast cancer and positive node involvement. In a series of 217 patients with breast cancer and positive nodes in whom the oncoprotein p185